Voyageur Pharmaceuticals (CVE:VM) Stock Price Down 11.5% – Time to Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price traded down 11.5% during mid-day trading on Saturday . The company traded as low as C$0.27 and last traded at C$0.27. 407,425 shares changed hands during mid-day trading, an increase of 105% from the average session volume of 198,342 shares. The stock had previously closed at C$0.31.

Voyageur Pharmaceuticals Price Performance

The stock has a market cap of C$40.91 million, a P/E ratio of -25.25 and a beta of 0.32. The company has a debt-to-equity ratio of 4.23, a quick ratio of 0.84 and a current ratio of 0.10. The business has a 50 day simple moving average of C$0.20 and a 200-day simple moving average of C$0.17.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.